Drug Class Reviews
by Drug Effectiveness Review Project
Publisher: Oregon Health & Science University 2009
Description:
Contents: Agents for Overactive Bladder; Alzheimer's Drugs; Atypical Antipsychotic Drugs; Beta Adrenergic Blockers; Beta2-Agonists; Calcium Channel Blockers; Constipation Drugs; Disease-modifying drugs for Multiple Sclerosis; HMG-CoA Reductase Inhibitors; Inhaled Corticosteroids; Long-Acting Opioid Analgesics; Drugs for Neuropathic Pain; Newer Antiemetics; Newer Antihistamines; Newer Antiplatelet Agents; Newer Drugs for Insomnia; Oral Hypoglycemics; etc.
Download or read it online for free here:
Download link
(multiple PDF files)
Similar books
![Book cover: Herbal Medicine: Biomolecular and Clinical Aspects](images/7573.jpg)
by Iris F. F. Benzie, Sissi Wachtel-Galor - CRC Press
This volume presents current scientific evidence of biomolecular effects of selected herbs and their relation to clinical outcome and promotion of human health. The book also addresses the ethical challenges of using herbal medicine.
(13959 views)
![Book cover: Gerry's Real World Guide to Pharmacokinetics and Other Things](images/3075.jpg)
by G. M. Woerlee - Booklocker.com, Inc.
The author of this book teaches the basic elements of pharmacokinetics of anesthetic drugs in the form of conversations between a curmudgeonly older anesthesiologist and an anesthesia resident as they administer anesthesia.
(15786 views)
![Book cover: Drugs, Brains and Behavior](images/3141.jpg)
by C. Robin Timmons, Leonard W. Hamilton - Rutgers University
From the table of contents: Behavior and the Chemistry of The Brain; General Methods of Brain/Behavior Analysis; Psychopharmacological Concepts; Specific Fears, Vague Anxieties And The Autonomic Nervous System; Pain and Other Stressors; etc.
(17785 views)
![Book cover: Genome-Based Therapeutics: Targeted Drug Discovery and Development](images/7960.jpg)
- National Academies Press
Objectives: to examine the impact of and investment in genetic and genomic technologies and data in drug development; to examine the challenges for incorporating genomic technologies into drug development and to to remedy those challenges.
(10141 views)